Silecs, Inc. develops and manufactures electronic and optical materials for semiconductors, image sensors, and displays to the microelectronics industry. Its materials solutions integrate with standard device manufacturing processes. The company's products are used in low temperature dielectric, CMOS sensor and other electro-optic, TFT-LCD displays and other optical, sub-Al IMD, BPSG leveling, partial and total etchback planarization, masking and other sacrificial, ultra low-k IMD, devices requiring low refractive index films, medium and high temperature, STI, PMD, thick film, passivation, and MEMS applications. It also provides local and regional customer support. The company has operating centers in Asia, the United States, and Europe; and a manufacturing, and research and development facility in Espoo, Finland. Silecs, Inc. was founded in 2000 and is headquartered in Mountain View, California
Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modified ÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. No significant adverse effects associated with the treatment was reported. The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
Medius is a leading global provider of accounts payable (AP) invoice automation solutions in the cloud. Our solutions automate and simplify the entire purchase-to-pay (P2P) process, enabling an unprecedented level of truly touchless invoice processing, shortened lead times, greater control, and improved visibility of financial metrics.
Projectplace creates collaborative tools that enable people and organizations to reach their goals. From the free ToDo collaboration tool to the complete project management platform, Projectplace brings secure and scalable collaboration to individuals, small businesses and large enterprises.
Hexaformer technology makes it possible to manufacture closed symmetrical delta shaped transformer cores, building transformer and reactor solutions to help their customers to improve the energy distribution in several aspects. The "green" properties, with e.g. low losses and less material used, are unique and have given us a substantial interest. Their robustness and their lower weight have also proven to be advantageous in several applications. Hexaformer manufactures its products in Västervik, Sweden. Their technology is also licensed to other manufacturers around the globe. The company was founded in 2004 and is now owned by a combination of strong venture capital companies and private individuals.
Jasper Design Automation, Inc. operates as an electronic design automation company. The company's products include JasperGold verification system that provides bug detection and debugging solutions; and GamePlan verification planner Web site. It offers verification products, IC design blocks, customer support, methodology consulting, training, and turnkey proof kit development. The company also provides on-site consulting services that enable the deployment and proliferation of structured verification methodologies, as well as write formal test plans for specific designs, and provides turnkey verification services. The company was founded in 1999 as Tempus Fugit, Inc. and changed its name to Jasper Design Automation, Inc. in 2003. Jasper Design Automation, Inc. is based in Mountain View, California
Silecs, Inc. develops and manufactures electronic and optical materials for semiconductors, image sensors, and displays to the microelectronics industry. Its materials solutions integrate with standard device manufacturing processes. The company's products are used in low temperature dielectric, CMOS sensor and other electro-optic, TFT-LCD displays and other optical, sub-Al IMD, BPSG leveling, partial and total etchback planarization, masking and other sacrificial, ultra low-k IMD, devices requiring low refractive index films, medium and high temperature, STI, PMD, thick film, passivation, and MEMS applications. It also provides local and regional customer support. The company has operating centers in Asia, the United States, and Europe; and a manufacturing, and research and development facility in Espoo, Finland. Silecs, Inc. was founded in 2000 and is headquartered in Mountain View, California
Isconova AB is an R&D company that develops and commercializes adjuvants and vaccines. It provides adjuvants for veterinary and human vaccines for an enhanced immune reaction with a longer duration. The products of the company include Matrix-M, which is a cell-mediated and antibody-mediated immune response for use in vaccines for humans, dogs, and cats. Matrix-C vaccines are used for horses, and Matrix-Q vaccines are used for cows and fish. Matrix-F is also used for fish. It also offers AbISCO research reagents, including AbISCO-100, for use in saponin-sensitive animal species, such as mice.
Novavax, Inc. is a late-stage biotechnology company based in Gaithersburg, Maryland, that specializes in the discovery, development, and commercialization of vaccines aimed at preventing serious infectious diseases. The company’s lead vaccine candidates include ResVax, designed to protect infants from respiratory syncytial virus (RSV) through maternal immunization, and NanoFlu, which targets seasonal influenza in older adults. Both of these candidates utilize the proprietary Matrix-M adjuvant to enhance immune responses. Novavax is also advancing a vaccine for RSV targeting older adults and children, as well as a candidate against the Ebola virus and a combination vaccine for influenza and RSV. Additionally, the company has initiated the development of a COVID-19 vaccine candidate, NVX-CoV2373, in collaboration with Takeda Pharmaceutical Company. Established in 1987, Novavax aims to address urgent global health needs through its innovative vaccine technologies.
Syntensia is a Stockholm, Sweden-based company that provides security on-demand solutions on subscription basis. Founded in 2005, the company focuses on providing all-in-one network security solutions for SMB in high growth emerging markets.
Enigma Semiconductor is developing next generation silicon solutions to enable the future of wired communications. Their solutions push the limits of technology to create compelling components and subsystems for applications such as Metropolitan and Access Networks, Enterprise and internet infrastructure and Storage Systems. Enigma is managed and stalled by a team of experienced professionals from established names like Cisco, intel and Vitesse Semiconductor.
SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. No significant adverse effects associated with the treatment was reported. The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
TRUE Personalisation – Personalisation that works. By combining big data with predictive analysis and real-time decisioning, Apptus eSales completes your eCommerce platform. It personalises product assortments across all screen real-estate and marketing campaigns, delivering unrivalled customer experiences. Welcome to the future of eCommerce.
Syntune supplies lasers for the telecommunications sector. The innovation reduces costs for WDM systems and will be a key component in the new "flexible bandwidth" fiber optic networks. Syntune acquired by Ignis ASA.
Hymite is a venture funded product company bringing to market the next generation packaging platform for use with High Power (HP) / Ultra-high Brightness (UHB) LEDs. Hymite's Engineered Silicon (Si) package platform delivers new levels of performance and value to their customers developing products for Solid State Lighting applications.
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.
Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modified ÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Resistentia Pharmaceuticals
Series C in 2006
Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiple sclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.
Ludesi is a rapidly growing bioinformatics company and the first company to offer image analysis of 2D electrophoresis gels as a globally accessible service. Their customers include some of the most prominent research institutes, pharmaceutical and biotech companies worldwide.
21GRAMS specializes in postal management services tailored for corporate clients. The company utilizes its technological expertise in postage optimization, alongside its extensive knowledge in post, print, and document management software. By doing so, 21GRAMS enables businesses to outsource the production of bulk mailings, streamline their communication processes, and substantially lower postage costs. This is achieved by identifying and capitalizing on savings opportunities within deregulated postage markets.
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.
Ipsat Therapies
Venture Round in 2006
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.
Cellartis AB is a Swedish/British biotechnology company focused on pluripotent stem cells and technology for drug discovery research, toxicity testing and regenerative medicine Since 2001, Cellartis has worked globally with industry and academia, platform providers and end users to develop the next generation of advanced stem cell products and technologies. The company leverages a deep experience in stem cell handling, scale up and differentiation into mature and functional human cells. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools today.
Dolthera GmbH is a biopharmaceutical company that is developing an innovative class of nucleic-acid-based anti-inflammatory drugs. These drugs, based on oligonucleotides that act as decoys for disease-related transcription factors are all directed against biologically validated targets in major chronic diseases with high unmet medical need. With this business concept and the underlying patent-protected technologies, AVONTEC won in 2003 the prestigious German Founders Award that is backed by McKinsey & Company. Initially, the Company has chosen to focus its patented technology on chronic inflammatory respiratory system and skin diseases. AVONTEC currently has five programs in respiratory disease, skin disease, transplant rejection, cardiovascular disease and autoimmune disease under development. All these indications represent areas with high unmet medical need and strong commercial potential.
NordNav Technologies is a developer of software GPS receivers for the mobile and automotive markets.
As of December 11, 2008 Taktio ApS went out of business. Taktio ApS develops and supplies man machine interfaces internationally. The company offers technology for high resolution and touch screen applications. Its products are used in mobile handset displays, computer monitors, windows, and glass walls. Taktio ApS was formerly known as O-pen ApS. The company was founded in 2003 and is based in Copenhagen, Denmark.
Syntune supplies lasers for the telecommunications sector. The innovation reduces costs for WDM systems and will be a key component in the new "flexible bandwidth" fiber optic networks. Syntune acquired by Ignis ASA.
Silecs, Inc. develops and manufactures electronic and optical materials for semiconductors, image sensors, and displays to the microelectronics industry. Its materials solutions integrate with standard device manufacturing processes. The company's products are used in low temperature dielectric, CMOS sensor and other electro-optic, TFT-LCD displays and other optical, sub-Al IMD, BPSG leveling, partial and total etchback planarization, masking and other sacrificial, ultra low-k IMD, devices requiring low refractive index films, medium and high temperature, STI, PMD, thick film, passivation, and MEMS applications. It also provides local and regional customer support. The company has operating centers in Asia, the United States, and Europe; and a manufacturing, and research and development facility in Espoo, Finland. Silecs, Inc. was founded in 2000 and is headquartered in Mountain View, California
Enigma Semiconductor is developing next generation silicon solutions to enable the future of wired communications. Their solutions push the limits of technology to create compelling components and subsystems for applications such as Metropolitan and Access Networks, Enterprise and internet infrastructure and Storage Systems. Enigma is managed and stalled by a team of experienced professionals from established names like Cisco, intel and Vitesse Semiconductor.
Hymite is a venture funded product company bringing to market the next generation packaging platform for use with High Power (HP) / Ultra-high Brightness (UHB) LEDs. Hymite's Engineered Silicon (Si) package platform delivers new levels of performance and value to their customers developing products for Solid State Lighting applications.
Appium Technologies
Venture Round in 2004
Appium is one of the leading vendors of next generation telecommunication application platforms and applications for the converging IT and Telecom market. To enable its business Appium delivers the leading telecom application platform and service creation environment for the OSA/Parlay market (www.parlay.org). Appium complements its service creation and deployment platforms offering with a range of commercially available applications and application components together with deployment and business models for addressing the enterprise as well as consumer market segments. Appium works in a standard Independent Software Vendor (ISV) business model. Appium addresses its offerings to Network Operators, Service Providers, Application Developers and, as the market evolves, Enterprises. Appium was founded in 1992, with head offices in Malmoe, Sweden, and originally provided professional services and solutions in the areas of Intelligent Networks, Mobile Systems, NGN and services. In 2000, the company decided to exploit the opportunities arising from the OSA/Parlay standards and was re-oriented to be a product company.
Proximion Fiber Optics Fiber Bragg Grating (FBG) technology, Proximion's product architecture embeds functionality into the optical layer to detect and counteract network faults and reduce the costs resulting from network downtime. The company's first product, WISTOM, combines both optical channel monitoring and optical performance monitoring onto one platform. With this high level of functionality, the system analyzes the performance of individual wavelength channels and pinpoints problems to be resolved to ensure Quality of Service (QoS) for network operators.
Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.
Proximion Fiber Optics Fiber Bragg Grating (FBG) technology, Proximion's product architecture embeds functionality into the optical layer to detect and counteract network faults and reduce the costs resulting from network downtime. The company's first product, WISTOM, combines both optical channel monitoring and optical performance monitoring onto one platform. With this high level of functionality, the system analyzes the performance of individual wavelength channels and pinpoints problems to be resolved to ensure Quality of Service (QoS) for network operators.
A vertical B2B portal for the printing industry.
TIBCO Software empowers executives, developers, and business users with Fast Data solutions that make the right data available in real time for faster answers, better decisions, and smarter action. Over the past 15 years, thousands of businesses across the globe have relied on TIBCO technology to integrate their applications and ecosystems, analyze their data, and create real-time solutions. Learn how TIBCO turns data—big or small—into differentiation at www.tibco.com.
TIBCO Software empowers executives, developers, and business users with Fast Data solutions that make the right data available in real time for faster answers, better decisions, and smarter action. Over the past 15 years, thousands of businesses across the globe have relied on TIBCO technology to integrate their applications and ecosystems, analyze their data, and create real-time solutions. Learn how TIBCO turns data—big or small—into differentiation at www.tibco.com.